Minimally important difference for the expanded prostate cancer index composite short form

Urology

Volumn 85, Issue 1, 2015, Pages 101-106

  Skolarus, Ted A ^a,b,c   Dunn, Rodney L ^a   Sanda, Martin G ^d   Chang, Peter ^e   Greenfield, Thomas K ^f   Litwin, Mark S ^g   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f PUBLIC HEALTH INSTITUTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER THERAPY; COHORT ANALYSIS; EXPANDED PROSTATE CANCER INDEX COMPOSITE SHORT FORM 26; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT SATISFACTION; PROSTATE CANCER; QUALITY OF LIFE; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; INFORMATION PROCESSING; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; QUESTIONNAIRE;

HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RECORDS AS TOPIC; SURVEYS AND QUESTIONNAIRES;

EID: 84918789680     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.08.044     Document Type: Article

References (23)

1. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
2. M. Darwish-Yassine, M. Berenji, and D. Wing Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study J Cancer Surviv 8 2014 121 130
3. J.L. Gore, L. Kwan, and S.P. Lee Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer J Natl Cancer Inst 101 2009 888 892
4. B.L. Jacobs, Y. Zhang, and T.A. Skolarus Comparative effectiveness of external-beam radiation approaches for prostate cancer Eur Urol 65 2012 162 168
5. T.A. Skolarus, A.Z. Weizer, and R.C. Hedgepeth Understanding early functional recovery after robotic prostatectomy Surg Innov 19 2012 5 10
6. F.R. Schroeck, T.L. Krupski, and L. Sun Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy Eur Urol 54 2008 785 793
7. K.M. Szymanski, J.T. Wei, R.L. Dunn, and M.G. Sanda Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors Urology 76 2010 1245 1250
8. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
9. D.C. Miller, M.G. Sanda, and R.L. Dunn Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy J Clin Oncol 23 2005 2772 2780
10. R.C. Chen, P. Chang, and R.J. Vetter Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials J Natl Cancer Inst 106 2014 Print 2014 Jul
11. D. Revicki, R.D. Hays, D. Cella, and J. Sloan Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J Clin Epidemiol 61 2008 102 109
12. K.W. Wyrwich, M. Bullinger, and N. Aaronson Estimating clinically significant differences in quality of life outcomes Qual Life Res 14 2005 285 295
13. D.T. Eton, D. Cella, and K.J. Yost A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale J Clin Epidemiol 57 2004 898 910
14. N. Kamo, S.V. Dandapani, and R.A. Miksad Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet Ann Oncol 22 2011 723 729
15. T.K. Greenfield, and C.C. Attkisson The UCSF Client Satisfaction Scales: II The Service Satisfaction Scale-30 M. Maruish, The Use of Psychological Testing for Treatment Planning and Outcome Assessment. Vol 3. Instruments for Adults 3rd ed. 2004 Lawrence Erlbaum Associates Mahwah, NJ 813 837
16. J.J. Chipman, M.G. Sanda, and R.L. Dunn Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice J Urol 191 2014 638 645
17. P. Chang, K.M. Szymanski, and R.L. Dunn Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer J Urol 186 2011 865 872
18. J.C. Wheat, R.C. Hedgepeth, and C. He Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score J Urol 182 2009 2844 2849
19. R.C. Hedgepeth, J. Labo, L. Zhang, and D.P. Wood Jr. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy J Urol 182 2009 221 227 discussion 227-228
20. R. Jayadevappa, S.B. Malkowicz, and M. Wittink Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors Health Serv Res 47 2012 1902 1925
21. J.V. Selby, A.C. Beal, and L. Frank The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda JAMA 307 2012 1583 1584
22. A.W. Wu, R.E. Jensen, C. Salzberg, and C. Snyder Advances in the Use of Patient Reported Outcome Measures in Electronic Health Records Including Case Studies Available at: http://www.pcori.org/assets/2013/11/PCORI-PRO-Workshop-EHR-Landscape-Review-111913.pdf 2013 Accessed December 17, 2013
23. M.A. Dall'Era, M.R. Cooperberg, and J.M. Chan Active surveillance for early-stage prostate cancer: review of the current literature Cancer 112 2008 1650 1659